Detailed Description
The invention will be further illustrated with reference to the following specific examples. It should be understood that these examples are for illustrative purposes only and are not intended to limit the scope of the present invention. The experimental procedures, in which specific conditions are not noted in the following examples, are generally carried out according to conventional conditions or according to conditions recommended by the manufacturers.
It is noted that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of exemplary embodiments according to the invention. As used herein, the singular forms "a", "an" and "the" are intended to include the plural forms as well, and it should be understood that when the terms "comprises" and/or "comprising" are used in this specification, they specify the presence of stated features, steps, operations, devices, components, and/or combinations thereof, unless the context clearly indicates otherwise.
At present, the electron mediator used for the electrochemical enzyme sensor in the prior art has the defects of higher oxidation-reduction potential, easy deletion and the like, and the invention provides a compound and a preparation method and application thereof in order to solve the problems.
In one or more embodiments of the invention, a compound is 1- (2- ((tert-butoxycarbonyl) amino) ethoxy) -5-ethylphenazin-5-ium having the following structure:
the 1- (2- ((tert-butoxycarbonyl) amino) ethoxy) -5-ethylphenazine-5-onium structure contains ethylphenazine and can be used as a redox center to realize rapid electron transfer, and meanwhile, the aminoethoxy on a side chain is used as a connecting modification center to stably connect enzyme or an electrode surface, so that the structure is favorable for reducing redox potential and avoiding loss of a mediator.
In one or more embodiments of the invention, a method of making a compound comprises:
step (1): dissolving N- (tert-butyloxycarbonyl) ethanolamine by dichloromethane, adding triethylamine and methylsulfonyl chloride for reaction, extracting and drying the crude product after the reaction is stopped, and performing rotary evaporation to obtain a sample 1;
step (2): dissolving 1-hydroxyphenyloxazine in N, N-dimethylformamide, adding potassium carbonate and the sample 1, heating for reaction, extracting after the reaction is stopped, drying, and performing rotary evaporation to obtain a sample 2;
and (3): dissolving the sample 2 in acetonitrile, adding iodoethane, heating for reaction, washing after the reaction is stopped, separating, and performing rotary evaporation to obtain the 1- (2- ((tert-butoxycarbonyl) amino) ethoxy) -5-ethylphenazine-5-onium.
In the preparation process, the adding sequence of the samples is controlled, and meanwhile, the adding types of the samples at each stage are controlled, so that certain influence is exerted on improving the purity of the product.
In one or more embodiments of the present invention, in step (1), the molar ratio of N- (tert-butoxycarbonyl) ethanolamine, triethylamine, and methylsulfonyl chloride is 8-12:10-15:10-15, preferably 10:13: 12. Under the addition proportion, the purity of the sample 1 can be improved, the generation of excessive impurities is avoided, the purification difficulty is reduced, and the purification efficiency is improved.
Or, in the step (1), the adding mode of the methylsulfonyl chloride is dropwise adding through a 0 ℃ constant pressure dropping funnel, and in the adding process, the temperature is too high, so that the reaction is not facilitated to be carried out, and therefore, the reaction can be effectively promoted to be carried out and the purity of the sample 1 can be improved through the dropwise adding mode through the 0 ℃ constant pressure dropping funnel.
Or, in the step (1), the reaction time is 8-15 min; preferably 10min, the reaction time is short, and the high-efficiency reaction is realized.
Or, in the step (1), the extraction method is to wash the sample 1 by using saturated sodium bicarbonate, saturated sodium chloride, a mixed solution of saturated sodium chloride and water and saturated sodium chloride in sequence, and the extraction method is favorable for quickly and efficiently purifying the sample 1 and avoids adverse effects of impurities on subsequent reactions.
Or, in the step (1), the rotary evaporation temperature is 30-50 ℃, preferably 40 ℃.
In one or more embodiments of the present invention, the specific operation in step (1) is: adding N- (tert-butyloxycarbonyl) ethanolamine into a round-bottom flask, dissolving the ethanolamine by using dichloromethane, adding triethylamine, dropwise adding methylsulfonyl chloride into a dropping funnel with a constant pressure of 0 ℃, stirring the mixture at room temperature for reaction, washing a crude product twice by using saturated sodium bicarbonate after the reaction is stopped, washing once by using saturated sodium chloride, washing once by using a mixed solution of the saturated sodium chloride and water, washing once by using the saturated sodium chloride, drying by using anhydrous sodium sulfate, and performing rotary evaporation at 40 ℃ by using a rotary evaporator.
In one or more embodiments of the invention, in step (2), the molar ratio of 1-hydroxyphenyloxazine to potassium carbonate to sample 1 is 0.5-1.2:1.5-2.5:0.8-1.5, preferably 1:2:1.2, and too high an amount of 1-hydroxyphenyloxazine added may result in more impurities, thereby increasing the difficulty of purification. The addition ratio of different reactants is well controlled, which is beneficial to obtaining a high-purity sample 2.
Or, in the step (2), the adding time of the sample 1 is 50 ℃ when the temperature is raised to 40-60 ℃; at this time, sample 1 had the best reaction efficiency with 1-hydroxyphenyloxazine.
Or, in the step (2), the reaction temperature is 70-90 ℃, preferably 80 ℃;
or, in the step (2), the reaction time is 1-4h, preferably 3 h;
or, in the step (2), the extraction method comprises washing with a mixed solution of water and ethyl acetate, washing the ethyl acetate layer with water, and then washing with saturated sodium chloride, and for the sample 2, it is necessary to purify with a mixed solution of water and ethyl acetate, which is beneficial to avoiding the generation of impurities.
Or, in the step (2), the rotary evaporation temperature is 30-50 ℃, preferably 40 ℃.
In one or more embodiments of the present invention, the specific operation of step (2) is: adding 1-hydroxyphenyloxazine into a round bottom flask, dissolving by using N, N-dimethylformamide, adding anhydrous potassium carbonate, adding the sample 1 when the temperature is raised to 40-60 ℃, heating and stirring for reaction, washing a crude product once by using a mixed solution of water and ethyl acetate after the reaction is stopped, washing an ethyl acetate layer twice by using water, washing once by using saturated sodium chloride, and carrying out rotary evaporation at the temperature of 30-50 ℃ by using a rotary evaporator.
In one or more embodiments of the present invention, in step (3), the molar ratio of sample 2 to iodoethane is 0.5-1.5:40-60, preferably 1:50, and an excessive amount of iodoethane generates impurities, and a too low amount of iodoethane does not achieve complete reaction with sample 2, resulting in low utilization.
Or, in the step (3), the heating reaction device is a sealed tube for heating, and the reaction temperature is 130-150 ℃, preferably 140 ℃; the tube sealing heating is beneficial to promoting the reaction, provides enough pressure and temperature for the reaction and reduces the generation of impurities.
Or, in the step (3), the reaction time is 8-12h, preferably 10 h;
or, in the step (3), the separation adopts a silica gel column separation mode; further, the volume ratio of the silica gel column gradient elution is ethyl acetate, dichloromethane: methanol 40:1, dichloromethane: methanol 30:1, dichloromethane: methanol 20:1, dichloromethane: methanol 10: 1; through silica gel column gradient elution, not only can the product purity be improved, but also the product yield can be improved.
Or, in the step (3), the rotary evaporation temperature is 30-50 ℃, preferably 40 ℃.
In one or more embodiments of the present invention, an electron mediator is a compound obtained by the above compound and/or the above compound preparation method.
The electron mediator, i.e. the molecular conductor, can effectively transfer electrons existing in the enzyme reaction center to the surface of the electrode, and then the current change is generated. The 1- (2- ((tert-butoxycarbonyl) amino) ethoxy) -5-ethylphenazine-5-onium is used as an electron mediator, and the compound contains conjugated pi electrons and can be overlapped with empty orbitals to be adsorbed by a substrate electrode. And secondly, the compound structure also has an electronic active group, so that the concentration of the group on the surface of the electrode can be increased, the sensing effect is good, the stability, the sensitivity and the reaction speed of the electrochemical enzyme sensor can be improved, and the immobilized enzyme cannot be poisoned. In addition, the compound 1- (2- ((tert-butoxycarbonyl) amino) ethoxy) -5-ethylphenazine-5-onium is in a low potential state in the redox reaction, so that the compound has stronger adsorption force on an electrode, and the service life and the anti-interference capability of an electrochemical enzyme sensor can be improved.
In one or more embodiments of the invention, the electrochemical enzyme sensor prepared by the novel compound has higher accuracy and sensitivity and higher stability.
In one or more embodiments of the invention, the use of the compound or a method of making the compound in the manufacture of an electrochemical enzyme sensor; further, the enzyme in the electrochemical enzyme sensor is selected from glucose oxidase, lactate oxidase, and horseradish peroxidase.
In one or more embodiments of the invention, the electrochemical enzyme sensor is applied to the fields of food safety, environmental detection and medicine development.
The present invention is described in further detail below with reference to specific examples, which are intended to be illustrative of the invention and not limiting.
Example 1
Preparation of 2- ((tert-butoxycarbonyl) amino) ethyl methanesulfonate:
adding N- (tert-butoxycarbonyl) ethanolamine (20mmol) into a round-bottom flask, dissolving the ethanolamine with 50mL of dichloromethane, adding triethylamine (26mmol), dropwise adding methylsulfonyl chloride (24mmol) into a dropping funnel at a constant pressure of 0 ℃, stirring the mixture at room temperature for reaction, washing a crude product after the reaction is stopped twice with 20mL of saturated sodium bicarbonate, once with 20mL of saturated sodium chloride, once with 10mL of mixed solution of saturated sodium chloride and 5mL of ultrapure water, once with 10mL of saturated sodium chloride, drying the product with anhydrous sodium sulfate, and performing rotary evaporation at 40 ℃ by using a rotary evaporator to obtain 2- ((tert-butoxycarbonyl) amino) ethyl methanesulfonate with the yield of 85%.
1HNMR(400MHz,CDCl3-d1)δ4.21(t,2H),3.41(t,2H),2.97(s,3H),1.38(s,9H).
Preparation of 1- ((tert-butoxycarbonyl) amino) ethoxyphenazine:
adding 1-hydroxyphenyloxazine (2.55mmol) into a round-bottom flask, dissolving the 1-hydroxyphenyloxazine with 50mL of N, N-dimethylformamide, adding anhydrous potassium carbonate (5.1mmol), adding a sample 1(3.06mmol) when the temperature is increased to 50 ℃, heating the mixture to 80 ℃, stirring the mixture for reaction, washing a crude product once with a mixed solution of 100mL of ultrapure water and 50mL of ethyl acetate after the reaction is stopped, taking an ethyl acetate layer, washing the ethyl acetate layer twice with 50mL of ultrapure water, washing with 20mL of saturated sodium chloride once, and performing rotary evaporation at 40 ℃ by using a rotary evaporator to obtain 1- (tert-butoxy) -N- (2- (phenazine-1-yloxy) ethyl) ethylamine with the yield of 74%.
1HNMR(400MHz,CDCl3-d1)δ8.40(d,1H),8.24(d,1H),7.86(t,1H),7.86(t,1H),7.86(t,1H),7.75(d,1H),7.18(d,1H),4.39(t,2H),3.77(q,2H),1.47(s,9H).
Preparation of 1- (2- ((tert-butoxycarbonyl) amino) ethoxy) -5-ethylphenazin-5-ium:
adding sample 2(0.15mmol) into a round-bottom flask, dissolving the sample with about 1mL of acetonitrile, adding iodoethane (7.5mmol), stirring the mixture in a sealed tube at 140 ℃, stopping the reaction after reacting for 10 hours, washing the mixture with diethyl ether, separating the crude product by a silica gel column, and performing gradient elution on the silica gel column by respectively using ethyl acetate, dichloromethane, methanol 40:1, dichloromethane, methanol 30:1, dichloromethane, methanol 20:1, dichloromethane, methanol 10:1, and finally performing rotary evaporation on the target component by using a rotary evaporator at 40 ℃ to obtain 1- (2- (((tert-butoxycarbonyl) amino) ethoxy) -5-ethylphenazine-5-onium.
1HNMR(400MHz,DMSO-d6)δ8.28(d,1H),8.27(d,1H),7.91(t,1H),7.88(t,1H),7.86(t,1H),7.86(d,1H),7.18(d,1H),4.20(m,2H),3.85(m,2H),3.64(t,2H),1.59(dd,3H)。
Example 2:
measurement of oxidation-reduction potential of the electron mediator:
the electron mediator 1- (2- ((tert-butoxycarbonyl) amino) ethoxy) -5-ethylphenazine-5-ium from example 1 was dissolved in PBS buffer and measured using an electrochemical workstation in which a glassy carbon electrode was the working electrode, Ag/AgCl was the reference electrode, a platinum wire was the counter electrode, and cyclic voltammetric scans were performed at a voltage of-1V to 1V.
The oxidation-reduction potential Em is-0.2V vs Ag/AgCl, and electrochemical detection can be carried out at a low working potential so as to avoid the influence of various interference factors.
Although the present invention has been described in detail with reference to the foregoing embodiments, it will be apparent to those skilled in the art that changes may be made in the embodiments and/or equivalents thereof without departing from the spirit and scope of the invention. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.